EP1526831A1 - Retinoid-containing preparations - Google Patents

Retinoid-containing preparations

Info

Publication number
EP1526831A1
EP1526831A1 EP03766186A EP03766186A EP1526831A1 EP 1526831 A1 EP1526831 A1 EP 1526831A1 EP 03766186 A EP03766186 A EP 03766186A EP 03766186 A EP03766186 A EP 03766186A EP 1526831 A1 EP1526831 A1 EP 1526831A1
Authority
EP
European Patent Office
Prior art keywords
weight
preparations
water
oil
retinoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP03766186A
Other languages
German (de)
French (fr)
Inventor
Axel Jentzsch
Andreas Habich
Christian KÖPSEL
Andreas Ernst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of EP1526831A1 publication Critical patent/EP1526831A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Definitions

  • the present invention relates to retinoid-containing preparations, their production and use in cosmetics, pharmacy and in the food sector.
  • Retinoids are among the most active ingredients that are used in cosmetics and dermatology. They work among other things regulating normal cell growth and influencing the differentiation of epithelial cells. For example, retinoic acids are used to treat acne and retinol in anti-wrinkle creams.
  • retinoids is severely restricted, which is due, among other things, to the high instability of the compounds. For this reason, strict precautionary measures must be observed when manufacturing preparations containing retinoids. For example, the production must take place completely under protective gas and the finished product must be packaged in an oxygen-impermeable manner.
  • EP-A-1 055 720 discloses the stabilization of oxygen-sensitive compounds by using thio compounds or glycoproteins in the absence of oxygen.
  • both water- and fat-soluble antioxidants are used together with chelating agents to stabilize retinoids.
  • This object was achieved by preparations containing at least one retinoid, at least one water-soluble antioxidant and at least one oil-soluble antioxidant, characterized in that in the preparations, per part by weight of retinoid, at least 1 part by weight of one or more water-soluble antioxidants and 0.1 to 100 parts by weight of one or more Oil-soluble antioxidants are present, the content of one or more water-soluble antioxidants being in the range from 0.05 to 0.8% by weight, based on the total amount of the preparations.
  • the preparations according to the invention are cosmetic and dermatological or pharmaceutical preparations and also preparations for the food sector.
  • Cosmetic preparations in particular skin care preparations, are preferred.
  • An advantageous embodiment of the preparations according to the invention contains 1 to 100 parts by weight, preferably 1 to 20 parts by weight, particularly preferably 1 to 5 parts by weight, very particularly preferably 2 to 3 parts by weight of one or more water-soluble antioxidants and 1 to 20 parts by weight, preferably 3, per part by weight of retinoid up to 10 parts by weight, particularly preferably 5 to 10 parts by weight, very particularly preferably 8 to 10 parts by weight of one or more oil-soluble antioxidants.
  • retinoids mean vitamin A alcohol (retinol) and its derivatives such as vitamin A aldehyde (retinal), vitamin A acid (retinoic acid) and vitamin A esters such as retinyl acetate and retinyl palmitate.
  • retinoic acid encompasses both all-trans retinoic acid and 13-cis retinoic acid.
  • retinol and retinal preferably include the all-trans compounds.
  • the preferred retinoid used for the preparations according to the invention is all-trans retinol.
  • the water-soluble antioxidants include ascorbic acid,
  • Preferred water-soluble antioxidants are ascorbic acid (L-ascorbic acid) and isoascorbic acid (D-ascorbic acid), particularly preferably L-ascorbic acid.
  • the L-ascorbic acid used with particular preference can be the free acid but also its salts.
  • Examples' games of salts of L-ascorbic acid are alkali metal or alkaline earth metal salts of L-ascorbic acid such as sodium L-ascorbate, potassium L-ascorbate or calcium L-ascorbate, as well as salts of L-ascorbic acid with an organic amine compound such as Choline ascorbate or L-carnitine ascorbate. Still more typically used 'free L-ascorbic acid or sodium L-ascorbate. The same applies to the use of D-ascorbic acid.
  • Oil-soluble antioxidants ascorbyl palmitate, butylated hydroxyanisole, ⁇ ⁇ -tocopherol, phenyl- ⁇ -naphthylamine or mixtures include butylated hydroxytoluene (BHT), meant thereof.
  • BHT butylated hydroxytoluene
  • the preferred oil-soluble antioxidant is ⁇ -tocopherol, which can be either (R, R, R) - or (all-rac) - ⁇ -tocopherol.
  • the preparations according to the invention generally contain 0.005 to 0.5% by weight, preferably 0.01 to 0.5% by weight, particularly preferably 0.03 to 0.15% by weight, very particularly preferably 0.04 up to 0.12% by weight of one or more retinoids, in particular all-trans-retinol, 0.05 to 0.8% by weight, preferably 0.1 to 0.5% by weight, particularly preferably 0.15 up to 0.3% by weight of one or more water-soluble antioxidants, in particular L-ascorbic acid, 0.0005 to 2% by weight, preferably 0.01 to 1.8% by weight, particularly preferably 0.1 to 1, 5 wt .-%, very particularly preferably 0.4 to 1.2 wt .-% of one or more oil-soluble antioxidants, in particular ⁇ -tocopherol.
  • the preparations of the invention are distinguished inter alia by the fact that can be omitted in their manufacture, bottling and storage of the use of inert gas' while ensuring a sufficient stability.
  • Sufficient stability in the sense of the invention is understood to mean that at least 90% of the retinoid is found in the preparation after 12 weeks of storage at 40 ° C. Further there are no undesirable color changes when the preparations according to the invention are stored.
  • the oxygen-impermeable packaging can be all commercially available packaging suitable for this purpose, e.g. Glass containers or aluminum packaging.
  • Aluminum tubes are preferably used, particularly preferably those aluminum tubes whose inside is additionally provided with a protective lacquer.
  • the cosmetic as well as the dermatological or pharmaceutical preparations are generally based on a carrier which contains at least one oil phase.
  • a carrier which contains at least one oil phase.
  • preparations on an aqueous basis alone are also possible. Accordingly, oils, creams, pastes or fat-free gels or preferably emulsions are suitable.
  • emulsions 0 / W emulsions, W / O emulsions, microemulsions or multiple emulsions such as O / W / O emulsions or W / O / W emulsions with one or more of the retinoids according to the invention, present in dispersed form, come in as emulsions Question, the emulsions are obtainable for example by phase inversion technology, according to DE-A-197 26 121.
  • Typical cosmetic auxiliaries which can be considered as additives to the cosmetic or pharmaceutical preparations are, for example, co-emulsifiers, fats and waxes, stabilizers, thickeners, biogenic active ingredients, film formers, fragrances, dyes, pearlescent agents, preservatives, pigments, electrolytes (e.g. Magnesium sulfate) and pH regulators.
  • co-emulsifiers for example, co-emulsifiers, fats and waxes, stabilizers, thickeners, biogenic active ingredients, film formers, fragrances, dyes, pearlescent agents, preservatives, pigments, electrolytes (e.g. Magnesium sulfate) and pH regulators.
  • co-emulsifiers e.g., sorbitan esters or partially esterified glycerides are preferred as co-emulsifiers.
  • Typical examples of fats are glycerides; waxes include beeswax, paraffin wax or microwaxes, optionally in combination with hydrophilic waxes.
  • Metal salts of fatty acids such as magnesium, aluminum and / or zinc stearate can be used as stabilizers.
  • Suitable thickeners are, for example, crosslinked polyacrylic acids and their derivatives, polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl cellulose, and also fatty alcohols, monoglycerides and fatty acids, polycrylates, polyvinyl alcohol and polyvinyl pyrrolidone.
  • Plant extracts, protein hydrolyzates and vitamin complexes are among the biogenic active ingredients understand.
  • Common film formers are, for example, hydrocolloids such as chitosan, microcrystalline chitosan or quaternized chitosan, polyvinylpyrrolidone, vinylpyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives and similar compounds.
  • Suitable preservatives are, for example, formaldehyde solution, p-hydroxybenzoate or sorbic acid.
  • Suitable pearlizing agents are, for example, glycol distearic acid esters such as ethylene glycol distearate, but also fatty acids and fatty acid monoglycol esters.
  • the dyes which can be used are those which are suitable and approved for cosmetic purposes, as compiled, for example, in the publication "Cosmetic Dyes” by the Dye Commission of the German Research Foundation, published by Verlag Chemie, Weinheim, 1984. These dyes are usually used in a concentration of 0.001 to 0.1% by weight, based on the mixture as a whole.
  • antioxidants are beneficial in many cases.
  • all antioxidants suitable or customary for cosmetic and / or dermatological applications can be used.
  • the antioxidants are advantageously selected from the group consisting of amino acids (eg glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (eg urocanic acid) and their derivatives, peptides such as D, L-carnosine, D-carnosine, L-carnosine and their derivatives (e.g. anserine), carotenoids, carotenes (e.g. ⁇ -carotene, lycopene) and their derivatives, chlorogenic acid and their derivatives, lipoic acid and their derivatives (e.g. dihydroliponic acid), aurothioglucose, propylthipuracil and other thiols (e.g.
  • amino acids eg glycine, histidine, tyrosine, tryptophan
  • imidazoles eg urocanic acid
  • peptides such as D, L-carnosine, D-carnosine, L
  • ⁇ -hydroxy fatty acids e.g. citric acid, lactic acid, malic acid
  • humic acid Bile acid, bile extracts, biliburin, biliverdin, EDTA and their derivatives
  • unsaturated fatty acids and their derivatives eg ⁇ -linolenic acid, linoleic acid, oleic acid
  • folic acid and its derivatives and coniferyl benzoate Benzoin, rutinic acid and its derivatives, ⁇ -glycosylrutin, ferulic acid, furfurylidene glucitol, carnosine, nordihydroguajak resin acid, nordihydrogua aretic acid, trihydroxybutyrophenone, uric acid and its derivatives, mannose and its derivatives, zinc and its derivatives,
  • the total amount of the aforementioned antioxidants (one or more compounds) in the preparations is preferably 0.075 to 30% by weight, particularly preferably 0.1 to 20% by weight, in particular 0.55 to 10% by weight, based on the Total weight of the preparation.
  • Typical oil components in cosmetics are, for example, paraffin oil, glyceryl stearate, isopropyl myristate, diisopropyl adipate, 2-ethylhexanoic acid cetyl stearyl ester, hydrogenated polyisobutene, petrolatum, caprylic acid / capric acid triglycerides, microcrystalline wax, lanolin and stearic acid.
  • the preparations according to the invention are suitable inter alia. as an additive for food, for example for the vitaminization of beverages and for the production of nutritional supplements in the human and animal sector.
  • retinoid-containing preparations in foods.
  • emulsions, solubilisates or water-dispersible dry powders in which mixtures of at least one retinoid, at least one water-soluble antioxidant and at least one oil-soluble antioxidant are present, can be used to vitaminize beverages.
  • milk products such as yogurt, milk mix drinks or milk ice cream.
  • the invention also relates to food supplements, animal feed, foodstuffs and pharmaceutical and cosmetic preparations containing the retinoid-containing preparations according to the invention.
  • Dietary supplements and pharmaceutical preparations which contain the retinoid mixture according to the invention include . To understand tablets, coated tablets and hard and soft gelatin capsules.
  • Phases A and B were heated separately to approx. 80 ° C. Phase B was then stirred into phase A and homogenized. Phase C was neutralized and post-homogenized. The cream was cooled to about 40 ° C. with stirring, phase D was stirred in and homogenized again.
  • the cream was then filled into aluminum tubes with an internal protective varnish.
  • Vitamin E acetate 0.30
  • Vitamin E acetate 0.50
  • Sun protection lotion (W / O emulsion)
  • PEG-7 hydrogenated castor oil 0.75 PEG-45 / dodecyl glycol copolymer 2.00
  • Liposome gel hydrophilic gel
  • Macadamia nut oil 5.00 propylene glycol 5.00
  • Macadamia nut oil 5.00 propylene glycol 5.00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Disclosed are preparations containing at least one retinoid, at least one water-soluble antioxidant, and at least one oil-soluble antioxidant. The invention is characterized by the fact that the preparations contain at least 1 part by weight of one or several water-soluble antioxidants and 0.1 to 100 parts by weight of one or several oil-soluble antioxidants per part by weight of retinoid, the content of one or several water-soluble antioxidants ranging between 0.05 and 0.8 percent by weight relative to the total quantity of the preparations.

Description

etinoid-haltige Zubereitungen preparations containing etinoid
Beschreibungdescription
Die vorliegende Erfindung betrifft Retinoid-haltige Zubereitungen, deren Herstellung und Verwendung in der Kosmetik, Pharmazie sowie im Nahrungsmittelbereich.The present invention relates to retinoid-containing preparations, their production and use in cosmetics, pharmacy and in the food sector.
Retinoide zählen mit zu den aktivsten Wirkstoffen, die in der Kosmetik und in der Dermatologie eingesetzt werden. Sie wirken u.a. regulierend auf das normale Zellwachstum und beeinflussen die Differenzierung von Epithelzellen. So werden Retinsäuren zur Behandlung von Akne und Retinol in Antifaltencremes eingesetzt.Retinoids are among the most active ingredients that are used in cosmetics and dermatology. They work among other things regulating normal cell growth and influencing the differentiation of epithelial cells. For example, retinoic acids are used to treat acne and retinol in anti-wrinkle creams.
Die Verwendung der Retinoide ist jedoch stark eingeschränkt, was unter anderem auf die hohe Instabilität der Verbindungen zurückzuführen ist. Aus diesem Grund müssen bei der Herstellung Retinoid-haltiger Zubereitungen strenge Vorsichtsmaßnahmen ein- gehalten werden. Beispielsweise muss die Herstellung vollständig unter Schutzgas erfolgen und das fertige Produkt Sauerstoffundurchlässig verpackt werden.However, the use of retinoids is severely restricted, which is due, among other things, to the high instability of the compounds. For this reason, strict precautionary measures must be observed when manufacturing preparations containing retinoids. For example, the production must take place completely under protective gas and the finished product must be packaged in an oxygen-impermeable manner.
Diese Anforderungen setzen eine anspruchsvolle technologische Ausstattung des Herstellers voraus und sind so mit hohen Herstellkosten verbunden.These requirements require sophisticated technological equipment from the manufacturer and are therefore associated with high manufacturing costs.
Es sind eine Reihe von Verfahren zur Stabilisierung von Retinoiden beschrieben worden. So offenbart EP-A-1 055 720 die Stabilisierung von sauerstoffempfindlichen Verbindungen durch Verwendung von Thioverbindungen oder Glycoproteinen unter Aus- schluss von Sauerstoff.A number of methods for stabilizing retinoids have been described. For example, EP-A-1 055 720 discloses the stabilization of oxygen-sensitive compounds by using thio compounds or glycoproteins in the absence of oxygen.
Gemäß WO 93/00085 und EP-A-0 440 398 werden sowohl wasser- als auch fettlösliche Antioxidantien zusammen mit Chelat-bildenden Mitteln zur Stabilisierung von Retinoiden eingesetzt.According to WO 93/00085 and EP-A-0 440 398, both water- and fat-soluble antioxidants are used together with chelating agents to stabilize retinoids.
Die beschriebenen Verfahren führen jedoch nicht immer zu einer ausreichenden Stabilisierung im Sinne der Erfindung. Vielmehr zeigen sowohl wasserlösliche Antioxidantien, insbesondere Ascorbinsäure, als auch fettlösliche Antioxidantien, insbesondere Tocopherol, im Zusammenhang mit Retinoiden in bestimmten Konzentrationsbereichen destabilisierende Wirkung.However, the methods described do not always lead to adequate stabilization in the sense of the invention. Rather, both water-soluble antioxidants, in particular ascorbic acid, and fat-soluble antioxidants, in particular tocopherol, have a destabilizing effect in connection with retinoids in certain concentration ranges.
Zudem kann es unter Umständen bei der Verwendung bestimmter Anti- oxidantienkombinationen zusammen mit Retinoiden zu unerwünschten Nebeneffekten, z.B. gelbliche Verfärbungen der Zubereitungen kommen, die die Verwendung dieser Systeme in der Kosmetik oder im Nahrungsmittelbereich unbrauchbar werden lassen.In addition, when using certain antioxidant combinations together with retinoids, there may be undesirable side effects, for example yellowish discoloration of the preparations come, which make the use of these systems in cosmetics or in the food sector unusable.
Es war daher Aufgabe der vorliegenden Erfindung, Retinoid-haltige Zubereitungen bereitzustellen, die die oben genannten Nachteile bezüglich Stabilität und Verfärbung nicht aufweisen und die einfach herzustellen sind.It was therefore an object of the present invention to provide retinoid-containing preparations which do not have the disadvantages mentioned above with regard to stability and discoloration and which are simple to prepare.
Diese Aufgabe wurde gelöst durch Zubereitungen, enthaltend mindestens ein Retinoid, mindestens ein wasserlösliches Antioxidans und mindestens ein öllösliches Antioxidans, dadurch gekennzeichnet, dass in den Zubereitungen pro Gewichtsteil Retinoid mindestens 1 Gewichtsteil eines oder mehrerer wasserlöslicher Antioxidantien und 0,1 bis 100 Gewichtsteile eines oder mehrerer öllöslicher Antioxidantien vorliegen, wobei der Gehalt an einem oder mehreren wasserlöslichen Antioxidantien im Bereich von 0,05 bis 0,8 Gew.-% liegt, bezogen auf die Gesamtmenge der Zubereitungen.This object was achieved by preparations containing at least one retinoid, at least one water-soluble antioxidant and at least one oil-soluble antioxidant, characterized in that in the preparations, per part by weight of retinoid, at least 1 part by weight of one or more water-soluble antioxidants and 0.1 to 100 parts by weight of one or more Oil-soluble antioxidants are present, the content of one or more water-soluble antioxidants being in the range from 0.05 to 0.8% by weight, based on the total amount of the preparations.
Bei den erfindungsgemäßen Zubereitungen handelt es sich um kosmetische und dermatologische bzw. pharmazeutische Zubereitungen sowie um Zubereitungen für den Nahrungsmittelbereich. Bevorzugt sind kosmetische Zubereitungen, insbesondere Hautpflegezubereitungen.The preparations according to the invention are cosmetic and dermatological or pharmaceutical preparations and also preparations for the food sector. Cosmetic preparations, in particular skin care preparations, are preferred.
Eine vorteilhafte Ausführungsform der erfindungsgemäßen Zubereitungen enthält pro Gewichtsteil Retinoid 1 bis 100 Gewichtsteile, bevorzugt 1 bis 20 Gewichtsteile, besonders bevorzugt 1 bis 5 Gewichtsteile, ganz besonders bevorzugt 2 bis 3 Gewichts- teile eines oder mehrerer wasserlöslicher Antioxidantien und 1 bis 20 Gewichtsteile, bevorzugt 3 bis 10 Gewichtsteile, besonders bevorzugt 5 bis 10 Gewichtsteile, ganz besonders bevorzugt 8 bis 10 Gewichtsteile eines oder mehrerer öllöslicher Antioxidantien.An advantageous embodiment of the preparations according to the invention contains 1 to 100 parts by weight, preferably 1 to 20 parts by weight, particularly preferably 1 to 5 parts by weight, very particularly preferably 2 to 3 parts by weight of one or more water-soluble antioxidants and 1 to 20 parts by weight, preferably 3, per part by weight of retinoid up to 10 parts by weight, particularly preferably 5 to 10 parts by weight, very particularly preferably 8 to 10 parts by weight of one or more oil-soluble antioxidants.
Unter Retinoide sind im Rahmen der vorliegenden Erfindung Vitamin A Alkohol (Retinol) und seine Derivate wie Vitamin A Aldehyd (Retinal) , Vitamin A Säure (Retinsäure) und Vitamin A Ester wie Retinylacetat und Retinylpalmitat gemeint. Der Begriff Retinsäure umfasst dabei sowohl all-trans Retinsäure als auch 13-cis Retinsäure. Die Begriffe Retinol und Retinal umfassen bevorzugt die all-trans Verbindungen. Als bevorzugtes Retinoid verwendet man ür die erfindungsgeiäßen Zubereitungen all-trans-Retinol .In the context of the present invention, retinoids mean vitamin A alcohol (retinol) and its derivatives such as vitamin A aldehyde (retinal), vitamin A acid (retinoic acid) and vitamin A esters such as retinyl acetate and retinyl palmitate. The term retinoic acid encompasses both all-trans retinoic acid and 13-cis retinoic acid. The terms retinol and retinal preferably include the all-trans compounds. The preferred retinoid used for the preparations according to the invention is all-trans retinol.
Als wasserlösliche Antioxidantien sind u.a. Ascorbinsäure,The water-soluble antioxidants include ascorbic acid,
Natriumsulfit, Natriummetabisulfit, Natriumbisulfit, Natriumthio- sulfit, Natriumformaldehydsulfoxylat, Isoascorbinsäure, Thio- glycerin, Thiosorbit, Thioharnstoff, Thioglykolsäure, Cystein- hydrochlorid, l,4-Diazobicyclo-(2 ,2,2)-oktan oder Mischungen davon gemeint.Sodium sulfite, sodium metabisulfite, sodium bisulfite, sodium thiosulfite, sodium formaldehyde sulfoxylate, isoascorbic acid, thiosulfite glycerol, thiosorbitol, thiourea, thioglycolic acid, cysteine hydrochloride, 1,4-diazobicyclo- (2,2,2) -octane or mixtures thereof.
Bevorzugte wasserlösliche Antioxidantien sind Ascorbinsäure (L-Ascorbinsäure) und Isoascorbinsäure (D-Ascorbinsäure) , besonders bevorzugt L-Ascorbinsäure.Preferred water-soluble antioxidants are ascorbic acid (L-ascorbic acid) and isoascorbic acid (D-ascorbic acid), particularly preferably L-ascorbic acid.
Bei der besonders bevorzugt verwendeten L-Ascorbinsäure kann es sich um die freie Säure aber auch um deren Salze handeln. Bei- ' spiele für Salze der L-Ascorbinsäure sind Alkali- oder Erdalkalimetallsalze der L-Ascorbinsäure wie Natrium-L-ascorbat , Kalium-L- ascorbat oder Calcium-L-ascorbat, aber auch Salze der L-Ascorbinsäure mit einer organischen Aminverbindung wie Cholinascorbat oder L-Carnitinascorbat . Ganz besonders bevorzugt verwendet man' die freie L-Ascorbinsäure oder Natrium-L-ascorbat. Entsprechendes gilt für die Verwendung von D-Ascorbinsäure.The L-ascorbic acid used with particular preference can be the free acid but also its salts. Examples' games of salts of L-ascorbic acid are alkali metal or alkaline earth metal salts of L-ascorbic acid such as sodium L-ascorbate, potassium L-ascorbate or calcium L-ascorbate, as well as salts of L-ascorbic acid with an organic amine compound such as Choline ascorbate or L-carnitine ascorbate. Still more typically used 'free L-ascorbic acid or sodium L-ascorbate. The same applies to the use of D-ascorbic acid.
Als öllösliche Antioxidantien sind u.a. butyliertes Hydroxytoluol (BHT), Ascorbylpalmitat, butyliertes Hydroxyanisol, α-Tocopherol, Phenyl-α-naphthylamin oder Mischungen davon gemeint.Oil-soluble antioxidants, ascorbyl palmitate, butylated hydroxyanisole, α-tocopherol, phenyl-α-naphthylamine or mixtures include butylated hydroxytoluene (BHT), meant thereof.
Bevorzugtes öllösliches Antioxidans ist α-Tocopherol, wobei es sich dabei sowohl um (R,R,R)- als auch um (all-rac) -α-Tocopherol handeln kann.The preferred oil-soluble antioxidant is α-tocopherol, which can be either (R, R, R) - or (all-rac) -α-tocopherol.
Die erfindungsgemäßen Zubereitungen enthalten in der Regel 0,005 bis 0,5 Gew.-%, bevorzugt 0,01 bis 0,5 Gew.-%, besonders bevorzugt 0,03 bis 0,15 Gew.-%, ganz besonders bevorzugt 0,04 bis 0,12 Gew.-% eines oder mehrerer Retinoide, insbesondere all- trans-Retinol, 0,05 bis 0,8 Gew.-%, bevorzugt 0,1 bis 0,5 Gew.-%, besonders bevorzugt 0,15 bis 0,3 Gew.-% eines oder mehrerer wasserlöslicher Antioxidantien, insbesondere L-Ascorbinsäure, 0,0005 bis 2 Gew.-%, bevorzugt 0,01 bis 1,8 Gew.-%, besonders bevorzugt 0,1 bis 1,5 Gew.-%, ganz besonders bevorzugt 0,4 bis 1,2 Gew.-% eines oder mehrerer öllöslicher Antioxidantien, insbesondere α-Tocopherol .The preparations according to the invention generally contain 0.005 to 0.5% by weight, preferably 0.01 to 0.5% by weight, particularly preferably 0.03 to 0.15% by weight, very particularly preferably 0.04 up to 0.12% by weight of one or more retinoids, in particular all-trans-retinol, 0.05 to 0.8% by weight, preferably 0.1 to 0.5% by weight, particularly preferably 0.15 up to 0.3% by weight of one or more water-soluble antioxidants, in particular L-ascorbic acid, 0.0005 to 2% by weight, preferably 0.01 to 1.8% by weight, particularly preferably 0.1 to 1, 5 wt .-%, very particularly preferably 0.4 to 1.2 wt .-% of one or more oil-soluble antioxidants, in particular α-tocopherol.
Die erfindungsgemäßen Zubereitungen zeichnen sich u.a. dadurch aus, dass bei deren Herstellung, Abfüllung und Lagerung auf die Verwendung von Schutzgas' verzichtet werden kann bei gleichzeitiger Gewährleistung einer ausreichenden Stabilität.The preparations of the invention are distinguished inter alia by the fact that can be omitted in their manufacture, bottling and storage of the use of inert gas' while ensuring a sufficient stability.
Unter ausreichender Stabilität im Sinne der Erfindung wird ver- standen, dass das Retinoid in der Zubereitung nach 12 Wochen Lagerung bei 40°C zu mindestens 90% wiedergefunden wird. Ferner kommt es bei der Lagerung der erfindungsgemäßen Zubereitungen zu keinen unerwünschten Farbveränderungen.Sufficient stability in the sense of the invention is understood to mean that at least 90% of the retinoid is found in the preparation after 12 weeks of storage at 40 ° C. Further there are no undesirable color changes when the preparations according to the invention are stored.
Von Vorteil ist es, wenn man die erfindungsgemäßen Zubereitungen in Sauerstoff-undurchlässigen Verpackungen aufbewahrt.It is advantageous if the preparations according to the invention are kept in oxygen-impermeable packaging.
Bei den Sauerstoff-undurchlässigen Verpackungen kann es sich um alle für diesen Zweck geeigneten handelsüblichen Verpackungen handeln wie z.B. Glasbehälter oder Aluminiumverpackungen. Bevor- zugt verwendet man Aluminiumtuben, besonders bevorzugt solche Aluminiumtuben, deren Innenseite zusätzlich mit einem Schutzlack versehen ist.The oxygen-impermeable packaging can be all commercially available packaging suitable for this purpose, e.g. Glass containers or aluminum packaging. Aluminum tubes are preferably used, particularly preferably those aluminum tubes whose inside is additionally provided with a protective lacquer.
Die kosmetischen sowie die dermatologischen oder pharmazeutischen Zubereitungen sind in der Regel auf der Basis eines Trägers, der mindestens eine Ölphase enthält. Es sind aber auch Zubereitungen allein auf wäεsriger Basis möglich. Demgemäß kommen Öle, Cremes, Pasten oder fettfreie Gele oder bevorzugt Emulsionen in Betracht.The cosmetic as well as the dermatological or pharmaceutical preparations are generally based on a carrier which contains at least one oil phase. However, preparations on an aqueous basis alone are also possible. Accordingly, oils, creams, pastes or fat-free gels or preferably emulsions are suitable.
Als Emulsionen kommen 0/W-Emulsionen, W/O-Emulsionen, Mikro- emulsionen oder multiple Emulsionen wie O/W/O-Emulsionen oder W/O/W-Emulsionen mit einem oder mehreren der in dispergierter Form vorliegenden, erfindungsgemäßen Retinoiden in Frage, wobei die Emulsionen beispielsweise durch Phaseninversionstechnologie, gemäß DE-A-197 26 121 erhältlich sind.0 / W emulsions, W / O emulsions, microemulsions or multiple emulsions such as O / W / O emulsions or W / O / W emulsions with one or more of the retinoids according to the invention, present in dispersed form, come in as emulsions Question, the emulsions are obtainable for example by phase inversion technology, according to DE-A-197 26 121.
Übliche kosmetische Hilfsstoffe, die als Zusätze zu den kosmetischen oder pharmazeutischen Zubereitungen in Betracht kommen können, sind z.B. Co-Emulgatoren, Fette und Wachse, Stabilisatoren, Verdickungsmittel, biogene Wirkstoffe, Filmbildner, Duftstoffe, Farbstoffe, Perlglanzmittel, Konservierungsmittel, Pigmente, Elektrolyte (z.B. Magnesiumsulfat) und pH- Regulatoren. Als Co-Emulgatoren kommen vorzugsweise bekannte W/0- und daneben auch O/W-Emulgatoren wie etwa Polyglycerinester, Sorbitanester oder teilveresterte Glyceride in Betracht. Typische Beispiele für Fette sind Glyceride; als Wachse sind u.a. Bienenwachs, Paraffinwachs oder Mikrowach.se gegebenenfalls in Kombination mit hydrophilen Wachsen zu nennen. Als Stabilisatoren können Metallsalze von Fettsäuren wie z.B. Magnesium-, Aluminium- und/oder Zinkstearat eingesetzt werden. Geeignete Verdickungsmittel sind beispielsweise vernetzte Polyacrylsäuren und deren Derivate, Polysaccharide, insbesondere Xanthan-Gum, Guar-Guar, Agar-Agar, Alginate und Tylosen, Carboxymethylcellulose und Hydroxyethylcellulose, ferner Fettalkohole, Monoglyceride und Fettsäuren, Polycrylate, Polyvinylalkohol und Polyvinyl- pyrrolidon. Unter biogenen Wirkstoffen sind beispielsweise Pflanzenextrakte, Eiweißhydrolysate und Vitaminkomplexe zu verstehen. Gebräuchliche Filmbildner sind beispielsweise Hydro- colloide wie Chitosan, mikrokristallines Chitosan oder quater- niertes Chitosan, Polyvinylpyrrolidon, Vinylpyrrolidon-Vinyl- acetat-Copolymerisate, Polymere der Acrylsäurereihe, quaternäre Cellulose-Derivate und ähnliche Verbindungen. Als Konservierungsmittel eignen sich beispielsweise Formaldehydlösung, p-Hydroxy- benzoat oder Sorbinsäure. Als Perlglanzmittel kommen beispielsweise Glycoldistearinsäureester wie Ethylenglycoldistearat , aber auch Fettsäuren und Fettsäuremonoglycolester in Betracht. Als Farbstoffe können die für kosmetische Zwecke geeigneten und zugelassenen Substanzen verwendet werden, wie sie beispielsweise in der Publikation "Kosmetische Färbemittel" der Farbstoff- koimmission der Deutschen Forschungsgemeinschaft, veröffentlicht im Verlag Chemie, Weinheim, 1984, zusammengestellt sind. Diese Farbstoffe werden üblicherweise in Konzentration von 0,001 bis 0,1 Gew. -%, bezogen auf die gesamte Mischung, eingesetzt.Typical cosmetic auxiliaries which can be considered as additives to the cosmetic or pharmaceutical preparations are, for example, co-emulsifiers, fats and waxes, stabilizers, thickeners, biogenic active ingredients, film formers, fragrances, dyes, pearlescent agents, preservatives, pigments, electrolytes (e.g. Magnesium sulfate) and pH regulators. Known W / O and, in addition, also O / W emulsifiers such as polyglycerol esters, sorbitan esters or partially esterified glycerides are preferred as co-emulsifiers. Typical examples of fats are glycerides; waxes include beeswax, paraffin wax or microwaxes, optionally in combination with hydrophilic waxes. Metal salts of fatty acids such as magnesium, aluminum and / or zinc stearate can be used as stabilizers. Suitable thickeners are, for example, crosslinked polyacrylic acids and their derivatives, polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl cellulose, and also fatty alcohols, monoglycerides and fatty acids, polycrylates, polyvinyl alcohol and polyvinyl pyrrolidone. Plant extracts, protein hydrolyzates and vitamin complexes are among the biogenic active ingredients understand. Common film formers are, for example, hydrocolloids such as chitosan, microcrystalline chitosan or quaternized chitosan, polyvinylpyrrolidone, vinylpyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives and similar compounds. Suitable preservatives are, for example, formaldehyde solution, p-hydroxybenzoate or sorbic acid. Suitable pearlizing agents are, for example, glycol distearic acid esters such as ethylene glycol distearate, but also fatty acids and fatty acid monoglycol esters. The dyes which can be used are those which are suitable and approved for cosmetic purposes, as compiled, for example, in the publication "Cosmetic Dyes" by the Dye Commission of the German Research Foundation, published by Verlag Chemie, Weinheim, 1984. These dyes are usually used in a concentration of 0.001 to 0.1% by weight, based on the mixture as a whole.
Die Verwendung weiterer Antioxidantien ist in vielen Fällen von Vorteil. So können zusätzlich zu den eingangs genannten erfindungsgemäßen Antioxidantien alle für kosmetische und/oder dermatologische Anwendungen geeignete oder gebräuchliche Antioxidantien verwendet werden.The use of other antioxidants is beneficial in many cases. Thus, in addition to the antioxidants according to the invention mentioned at the outset, all antioxidants suitable or customary for cosmetic and / or dermatological applications can be used.
Vorteilhafterweise werden die Antioxidantien gewählt aus der Gruppe, bestehend aus Aminosäuren (z.B. Glycin, Histidin, Tyrosin, Tryptophan) und deren Derivate, Imidazole (z.B. Urocaninsäure) und deren Derivate, Peptide wie D,L-Carnosin, D-Carnosin, L-Carnosin und deren Derivate (z.B. Anserin) , Carotinoide, Carotine (z.B. ß-Carotin, Lycopin) und deren Derivate, Chlorogensäure und deren Derivate, Liponsäure und deren Derivate (z.B. Dihydroliponsäure) , Aurothioglucose, Propyl- thipuracil und andere Thiole (z .B. " Thiorodoxin, Glutathion, Cystin, Cystamin und deren Glycosyl-, N-Acetyl-, Methyl-, Ethyl-, Propyl-, Ayl-, Butyl-, und Lauryl-, Pal itoyl-, Oleyl-, γ-Linoleyl-, Cholesteryl- und Glycerylester) sowie deren Salze, Dilaurylthiodipropionat , Distearylthiodipropionat, Thiodi- propionsäuure und deren Derivate (Ester, Ether, Peptide, Lipide, Nukleotide, Nukleoside und Salze) sowie Sulfoximinverbindungen (z.B. Buthioninsulfoxi ine, Homocysteinsulfoximine, Buthionin- sulfone, Penta-, Hexa-, Heptathioninsulfoximin) in sehr geringen verträglichen Dosierungen (z.B. pmol bis μmol/kg) , ferner (Metall)-Chelatoren (z.B. α-Hydroxyfettsäuren, Palmitinsäure, Phytinsäure, Lactoferrin) , α-Hydroxysäuren (z.B. Citronensäure, Milchsäure, Apfelsäure) , Huminsäure, Gallensäure, Gallenextrakte, Biliburin, Biliverdin, EDTA und deren Derivate, ungesättigte Fettsäuren und deren Derivate (z.B. γ-Linolensäure, Linolsäure, Ölsäure) , Folsäure und deren Derivate sowie Koniferylbenzoat des Benzoeharzes, Rutinsäure und deren Derivate, α-Glycosylrutin, Ferulasäure, Furfurylidenglucitol, Carnosin, Nordihydroguajak- harzsäure, Nordihydrogua aretsäure, Trihydroxybutyrophenon, Harnsäure und deren Derivate, Mannose und deren Derivate, Zink und dessen Derivate (z.B. ZnO, ZnS04) , Selen und dessen Derivate (z.B. Selenmethionin) , Stilbene und deren Derivate (z.B. Stilbenoxid, Trans-Stilbenoxid) .The antioxidants are advantageously selected from the group consisting of amino acids (eg glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (eg urocanic acid) and their derivatives, peptides such as D, L-carnosine, D-carnosine, L-carnosine and their derivatives (e.g. anserine), carotenoids, carotenes (e.g. β-carotene, lycopene) and their derivatives, chlorogenic acid and their derivatives, lipoic acid and their derivatives (e.g. dihydroliponic acid), aurothioglucose, propylthipuracil and other thiols (e.g. " Thiorodoxin, glutathione, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, ayl, butyl, and lauryl, pal itoyl, oleyl, γ-linoleyl, cholesteryl - And glyceryl esters) as well as their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and its derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) as well as sulfoximine compounds (eg buthioninsulfoximines, homocysteine sulfoximines, pentane- hexane sulfate) - , Heptathioninsulfoximine) in very low tolerable doses (e.g. pmol to μmol / kg), also (metal) chelators (e.g. α-hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), α-hydroxy acids (e.g. citric acid, lactic acid, malic acid), humic acid, Bile acid, bile extracts, biliburin, biliverdin, EDTA and their derivatives, unsaturated fatty acids and their derivatives (eg γ-linolenic acid, linoleic acid, oleic acid), folic acid and its derivatives and coniferyl benzoate Benzoin, rutinic acid and its derivatives, α-glycosylrutin, ferulic acid, furfurylidene glucitol, carnosine, nordihydroguajak resin acid, nordihydrogua aretic acid, trihydroxybutyrophenone, uric acid and its derivatives, mannose and its derivatives, zinc and its derivatives, zinc and its derivatives (eg, ZnO 4 ) and selenium ( 4 ) its derivatives (eg selenium methionine), stilbenes and their derivatives (eg stilbene oxide, trans-stilbene oxide).
Die Gesamtmenge der vorgenannten Antioxidantien (eine oder mehrere Verbindungen) in den Zubereitungen beträgt vorzugsweise 0,075 bis 30 Gew.-%, besonders bevorzugt 0,1 bis 20 Gew.-%, insbesondere 0,55 bis 10 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitung.The total amount of the aforementioned antioxidants (one or more compounds) in the preparations is preferably 0.075 to 30% by weight, particularly preferably 0.1 to 20% by weight, in particular 0.55 to 10% by weight, based on the Total weight of the preparation.
Übliche Ölkomponenten in der Kosmetik sind beispielsweise Paraffinöl, Glycerylstearat, Isopropylmyristat, Diisopropyl- adipat, 2-Ethylhexansäurecetylstearylester, hydriertes Poly- isobuten, Vaseline, Caprylsäure/Caprinsäure-Triglyceride, mikrokristallines Wachs, Lanolin und Stearinsäure.Typical oil components in cosmetics are, for example, paraffin oil, glyceryl stearate, isopropyl myristate, diisopropyl adipate, 2-ethylhexanoic acid cetyl stearyl ester, hydrogenated polyisobutene, petrolatum, caprylic acid / capric acid triglycerides, microcrystalline wax, lanolin and stearic acid.
Die erfindungsgemäßen Zubereitungen eignen sich u.a. als Zusatzstoff für Lebensmittel, beispielsweise zur Vitaminierung von Getränken und für die Herstellung von Nahrungsergänzungs- präparaten im Human- und Tierbereich.The preparations according to the invention are suitable inter alia. as an additive for food, for example for the vitaminization of beverages and for the production of nutritional supplements in the human and animal sector.
Für die Verwendung der erfindungsgemäßen Retinoid-haltigen Zubereitungen in Lebensmitteln eignen sich prinzipiell alle der oben genannten Formulierungsarten. So können zum Vitaminieren von Getränken beispielsweise Emulsionen, Solubilisate oder auch wasser-dispergierbare Trockenpulver verwendet werden, in denen Mischungen von mindestens einem Retinoid, mindestens einem wasserlöslichen Antioxidans und mindestens einem öllöslichen Antioxidans vorliegen.In principle, all of the above-mentioned types of formulation are suitable for the use of the retinoid-containing preparations according to the invention in foods. For example, emulsions, solubilisates or water-dispersible dry powders, in which mixtures of at least one retinoid, at least one water-soluble antioxidant and at least one oil-soluble antioxidant are present, can be used to vitaminize beverages.
Es ist aber auch möglich Emulsionen, die die erfindungsgemäßen Retinoid-haltigen Zubereitungen enthalten, Milchprodukten wie Joghurt, Milchmixgetränken oder Milchspeiseeis zuzugeben.However, it is also possible to add emulsions which contain the retinoid-containing preparations according to the invention, milk products such as yogurt, milk mix drinks or milk ice cream.
Gegenstand der Erfindung sind auch Nahrungsergänzungsmittel, Tierfuttermittel, Lebensmittel sowie pharmazeutische und kosmetische Zubereitungen, enthaltend die erfindungsgemäßen Retinoid-haltigen Zubereitungen. Unter Nahrungsergänzungspräparaten sowie pharmazeutische Zubereitungen, die die erfindungsgemäße Retinoidmischung enthalten, sind u.a.. Tabletten, Dragees sowie Hart- und Weichgelatinekapseln zu verstehen.The invention also relates to food supplements, animal feed, foodstuffs and pharmaceutical and cosmetic preparations containing the retinoid-containing preparations according to the invention. Dietary supplements and pharmaceutical preparations which contain the retinoid mixture according to the invention include . To understand tablets, coated tablets and hard and soft gelatin capsules.
Herstellverfahren:manufacturing:
Es bestehen zahlreiche Möglichkeiten zur Herstellung einer kosmetischen Zubereitung. So kommen das Heiß/Heiß-Verfahren, das Heiß/Kalt-Verfahren oder das Kalt/Kalt-Verfahren, wie sie zum Beispiel in "Kosmetik - Entwicklung, Herstellung und Anwendung kosmetischer Mittel", Hrsg. Wilfried Umbach, Thieme Verlag, 1995, Seite 511 beschrieben sind, zur Verwendung. Mit Hilfe dieser Verfahren lassen sich Öl-in-Wasser (0/W-) , Wasser-in-Öl (W/0-) , aber auch multiple Emulsionen sowie Cremegele und Gele herstellen. Die Einarbeitung der Wirkstoffe erfolgt dabei bevorzugt nach dem Abkühlen der Formulierung auf unter 40°C, in besonders empfindlichen Fällen bevorzugt nach dem Abkühlen auf Raumtemperatur. Für die dieser Erfindung zugrundeliegenden Untersuchungen wurde eine 0/W- Emulsion im Heiß/Heiß-Verfahren hergestellt und die Wirkstoffe anschließend bei Raumtemperatur in die fertige Formulierung eingearbeitet.There are numerous options for producing a cosmetic preparation. Thus come the hot / hot process, the hot / cold process or the cold / cold process, as described, for example, in "Cosmetics - Development, Production and Use of Cosmetic Agents", ed. Wilfried Umbach, Thieme Verlag, 1995, Page 511 are described for use. These processes can be used to produce oil-in-water (0 / W-), water-in-oil (W / 0-), but also multiple emulsions as well as cream gels and gels. The active ingredients are preferably incorporated after the formulation has cooled to below 40 ° C., in particularly sensitive cases preferably after cooling to room temperature. For the studies on which this invention is based, a 0 / W emulsion was produced in a hot / hot process and the active ingredients were then incorporated into the finished formulation at room temperature.
Die verwendete Rezeptur:The recipe used:
Inhaltsstoff INCIIngredient INCI
Phase A 2.00 Cremophor A 6 Ceteareth-β , Stearyl AlcoholPhase A 2.00 Cremophor A 6 ceteareth-β, stearyl alcohol
2.00 Cre ophor A 25 Ceteareth-252.00 Cre ophor A 25 Ceteareth-25
3.00 Jojobaöl Simmondsia Chinensis (Jojoba) Seed Oil3.00 Jojoba Oil Simmondsia Chinensis (Jojoba) Seed Oil
3.00 Cetylstearyl Alcohol Cetearyl Alcohol3.00 Cetylstearyl Alcohol Cetearyl Alcohol
10.00 Paraffinöl, dickflüssig Mineral Oil10.00 paraffin oil, viscous mineral oil
5.00 Vaseline Petrolatum5.00 petrolatum petrolatum
4.00 Miglyol 812 Caprylic/Capric Tri- glyceride4.00 Miglyol 812 Caprylic / Capric Triglyceride
0.10 BHT BHT Phase B 5.00 1, 2-Propylenglykol Propylene Glycol USP0.10 BHT BHT Phase B 5.00 1, 2-propylene glycol Propylene Glycol USP
0.10 Edeta BD Disodium EDTA0.10 Edeta BD Disodium EDTA
20.00 Carbopol 934, Carbomer8:00 pm Carbopol 934, Carbomer
1% in Wasser dem.1% in water.
0.30 Chemag 2000 ad 100 Water dem. Aqua dem.0.30 Chemag 2000 ad 100 Water dem. Aqua dem.
Phase C 0.80 Natriumhydroxyd, Sodium HydroxidePhase C 0.80 sodium hydroxide, sodium hydroxide
10% in Wasser dem.10% in water.
Phase D 0.50 Vitamin E-Acetat Tocopheryl AcetatePhase D 0.50 Vitamin E Acetate Tocopheryl Acetate
0.20 Phenoxyethanol Phenoxyethanol q.s. Parfümöl Herstellung:0.20 phenoxyethanol phenoxyethanol q.s. Perfume oil manufacture:
Die Phasen A und B wurden getrennt auf ca. 80°C erwärmt. Phase B wurde dann in Phase A eingerührt und homogenisiert. Mit Phase C wurde neutralisiert und nachhomogenisiert. Unter Rühren wurde die Creme auf ca. 40°C abgekühlt, Phase D eingerührt und nochmals homogenisiert .Phases A and B were heated separately to approx. 80 ° C. Phase B was then stirred into phase A and homogenized. Phase C was neutralized and post-homogenized. The cream was cooled to about 40 ° C. with stirring, phase D was stirred in and homogenized again.
Die wasserlöslichen sowie die öllöslichen Antioxidantien wurden anschließend, nach Abkühlen der Creme auf Raumtemperatur in die fertige Emulsion eingearbeitet. Dabei wurde zunächst D,L-alpha- Tocopherol zugegeben, dann die Ascorbinsäure und anschließend Retinol (Retinol 15D®, BASF; 15 %ige Lösung von Retinol in einem mittelkettigen Triglycerid) unter Rühren eingearbeitet.The water-soluble and the oil-soluble antioxidants were then incorporated into the finished emulsion after the cream had cooled to room temperature. Initially D, L-alpha-tocopherol was added, then the ascorbic acid and then retinol (Retinol 15D ®, BASF; 15% solution of retinol in a medium chain triglyceride) is incorporated with stirring.
Anschließend wurde die Creme in Aluminiumtuben mit Innenschutz- lack abgefüllt.The cream was then filled into aluminum tubes with an internal protective varnish.
Nach dem oben beschriebenen Herstellverfahren wurden Cremes mit unterschiedlichen Mengen an Retinol, (all-rac) -α-Tocopherol und L-Ascorbinsäure hergestellt und für StabilitätsuntersuchungenAccording to the manufacturing process described above, creams with different amounts of retinol, (all-rac) -α-tocopherol and L-ascorbic acid were produced and for stability studies
12 Wochen bei 40°C gelagert. Das Ergebnis dieses Stabilitätstests findet sich in der folgenden Tabelle: Anhand der folgenden Beispielformulierungen wird der Gegenstand der Erfindung näher erläutert.Stored at 40 ° C for 12 weeks. The result of this stability test can be found in the following table: The subject matter of the invention is explained in more detail using the following example formulations.
Beispiel 1example 1
Hautlotion (O/W-Eulsion)Skin lotion (O / W emulsion)
% W/W Ceteareth-6 und Stearylalkohol 2,50% W / w ceteareth-6 and stearyl alcohol 2.50
Ceteareth-25 2,50Ceteareth-25 2.50
Hydriertes Cocoglycerid 1,50Hydrogenated cocoglyceride 1.50
PEG-40 Dodecyl Glykol Copolymer 3,00PEG-40 dodecyl glycol copolymer 3.00
Dirnethicone 3,00 Phenethyl Dimethicone 2,00Dirnethicone 3.00 Phenethyl Dimethicone 2.00
Cyc1omethicone 1,00Cyclomethicone 1.00
Cetearyloctanoat 5,00Cetearyl octanoate 5.00
Avocadoöl 1,00Avocado oil 1.00
Mandelöl 2,00 eizenkeimöl 0,80Almond oil 2.00 germ oil 0.80
Panthenol USP 1,00Panthenol USP 1.00
Phytantriol 0,20Phytantriol 0.20
Vitamin E-Acetat 0,30Vitamin E acetate 0.30
Propylenglyko1 5,00 Parfüm q.s.Propylene Glyco1 5.00 Perfume q.s.
Konservierungsmittel q.s.Preservatives q.s.
Ascorbinsäure 0,20Ascorbic acid 0.20
Retinol 15D® 0,20Retinol 15D ® 0.20
Tocopherol 0,10 Wasser ad 100Tocopherol 0.10 water ad 100
Beispiel 2Example 2
Handcreme (W/O-Emulsion)Hand cream (w / o emulsion)
% W/W% W / W
Cetearylalkohol 1,00Cetearyl alcohol 1.00
Glycerylstearat 1,50Glyceryl stearate 1.50
Stearylalkohol 1,50Stearyl alcohol 1.50
Cetylpalmitat 2,00Cetyl palmitate 2.00
Vitamin E-Acetate 0,50Vitamin E acetate 0.50
Dimethicone 8,00Dimethicone 8.00
Ceteareth-6 and Stearylalkohol 3,00Ceteareth-6 and stearyl alcohol 3.00
Octyl Methoxycinnamate 5,00Octyl methoxycinnamate 5.00
Propylenglykol 8,00Propylene glycol 8.00
Panthenol 1,00Panthenol 1.00
Nachtkerzenöl 3,00 PEG-7 Hydriertes Castoröl 6,00 Glycery1o1eat 1,00 Phenethyl Dimethicone 3,00 Bienenwachs 1,50 Johannisbrotkernmehl 0,80 Seidenpuder 0,80 Konservierungsmittel q.s. Parfüm, q.s. Borax 0,10 Natriumascorbat 0,30 Tocopherol 0,60 Retinol 15D ,® 0,66 Wasser ad 100Evening primrose oil 3.00 PEG-7 hydrogenated castor oil 6.00 glycery1o1eat 1.00 phenethyl dimethicone 3.00 beeswax 1.50 locust bean gum 0.80 silk powder 0.80 preservative qs perfume, qs borax 0.10 sodium ascorbate 0.30 tocopherol 0.60 retinol 15D, ® 0.66 water ad 100
Beispiel 3Example 3
Sonnenschutzlotion (W/O-Emulsion)Sun protection lotion (W / O emulsion)
% W/W PEG-7 Hydriertes Castoröl 6,00% W / W PEG-7 hydrogenated castor oil 6.00
PEG-40 Hydriertes Castoröl 0,50PEG-40 hydrogenated castor oil 0.50
Isopropylpalmitat 7,00Isopropyl palmitate 7.00
PEG-45/Dodecyl Glykol Coplymer 2,00PEG-45 / Dodecyl Glycol Coplymer 2.00
Jojobaöl 3,00 Magnesiumstearat 0,60Jojoba oil 3.00 magnesium stearate 0.60
Octyl Methoxycinna ate 8,00Octyl methoxycinna ate 8.00
C 12-15 Alkyl Benzoat 5,00C 12-15 alkyl benzoate 5.00
Titaniumdioxid 4,00Titanium dioxide 4.00
Propylene Glykol 5,00 EDTA 0,20Propylene glycol 5.00 EDTA 0.20
Konservierungsmittel q. s.Preservatives q. s.
Retinol 15D® 0,33Retinol 15D ® 0.33
Wasser ad 100Water ad 100
Natriumascorbylphospat 1,00 Vitamin E-Acetat 0,50Sodium ascorbyl phosphate 1.00 vitamin E acetate 0.50
Natriumascorbat 0,20Sodium ascorbate 0.20
Tocopherol 1,00Tocopherol 1.00
Parfüm q.s. Beispiel 4Perfume qs Example 4
Multiple Emulsion (W/O/W-Emulsion)Multiple emulsion (W / O / W emulsion)
% W/W% W / W
Parafinöl 7,50Paraffin oil 7.50
Cetearyloctanoat 2,50Cetearyl octanoate 2.50
Aluminiumstearat 0,25Aluminum stearate 0.25
Magnesiumstearat 0,25 Mikrokristallines Wachs H 0,50Magnesium stearate 0.25 microcrystalline wax H 0.50
Cetearylalkohol 1,00Cetearyl alcohol 1.00
Lanolinalkohol 1,50Lanolin alcohol 1.50
Wollwachsalkoholsalbe 1,50Wool wax alcohol ointment 1.50
PEG-7 Hydriertes Castoröl 0,75 PEG-45/Dodecyl Glyokol Copolymer 2,00PEG-7 hydrogenated castor oil 0.75 PEG-45 / dodecyl glycol copolymer 2.00
Ceteareth-6 and Stearylalkohol 2,00Ceteareth-6 and stearyl alcohol 2.00
Ceteareth-25 2,00Ceteareth-25 2.00
Trilauret-4 Phosphat 1,00Trilauret-4 phosphate 1.00
Hydroxyethylcellulose 0,20 Propylenglykol 7,50Hydroxyethyl cellulose 0.20 propylene glycol 7.50
Magnesiumsulfat 0,25Magnesium sulfate 0.25
Ascorbinsäure 0,30Ascorbic acid 0.30
Tocopherol 0,01Tocopherol 0.01
Retinol 15D -.ees) 0,40 Wasser ad 100Retinol 15D -. e es) 0.40 water ad 100
Beispiel 5Example 5
Microemulsionmicroemulsion
% W/W% W / W
Ceteareth-25 13,00Ceteareth-25 13.00
PEG-7 Glycerylcocoat 20,00PEG-7 glyceryl cocoate 20.00
Octyldodecanol 5,00 Konservierungsmittel q.s.Octyldodecanol 5.00 preservative q.s.
Ascorbinsäure 0,10Ascorbic acid 0.10
Tocopherol 0,10Tocopherol 0.10
Retinol 15D -,5® 0,66Retinol 15D -, 5 ® 0.66
Wasser ad 100 Beispiel 6Water ad 100 Example 6
Liposomgel (hydrophiles Gel)Liposome gel (hydrophilic gel)
% W/W% W / W
PEG-40 Hydriertes Castoröl 1,00PEG-40 hydrogenated castor oil 1.00
Bisabolol rac. 0,10Bisabolol rac. 0.10
Propyleneglykol 8,00Propylene glycol 8.00
Panthenoi 0,50Panthenoi 0.50
Wasser, Vitamim E-Acetat, Polysorbate 80 and Caprylic/CapricWater, Vitamim E-Acetate, Polysorbate 80 and Caprylic / Capric
Triglyceride und Lecithin 3,00Triglycerides and lecithin 3.00
Konservierungsmittel q.s.Preservatives q.s.
Parfüm q.s.Perfume q.s.
Carbomer 0,50Carbomer 0.50
Ascorbinsäure 0,15Ascorbic acid 0.15
Tocopherol 0,15Tocopherol 0.15
Triethanolamin 0,70Triethanolamine 0.70
Retinol 15D® 0,33 Wasser ad 100Retinol 15D ® 0.33 water ad 100
Beispiel 7Example 7
Cooling Body Splash (wässrige Kosmetik)Cooling Body Splash (water-based cosmetics)
% W/W% W / W
PEG-40 Hydriertes Castoröl 2,00PEG-40 hydrogenated castor oil 2.00
Menthyllac at 0,20Menthyllac at 0.20
Alkohol 5,00 PEG-7 Glycerylcocoate 2,00Alcohol 5.00 PEG-7 glyceryl cocoate 2.00
Hamamelis 5,00Witch Hazel 5.00
Allantoin- 0,10Allantoin - 0.10
Bisabolol rac. 0,20Bisabolol rac. 0.20
Propylenglykol 5,00 Panthenol USP 0,50Propylene glycol 5.00 panthenol USP 0.50
Milchsäure (80%ig) 0,20Lactic acid (80%) 0.20
Ascorbinsäure 0,50Ascorbic acid 0.50
Tocopherol 0,30Tocopherol 0.30
Parfüm q.s. Retinol 15D® 0,20Perfume qs Retinol 15D ® 0.20
Wasser ad 100 Beispiel 8Water ad 100 Example 8
Make-up (Dekorative Kosmetik)Make-up (decorative cosmetics)
% W/W% W / W
Ceteareth-6 and Stearylalkohol 9,00Ceteareth-6 and stearyl alcohol 9.00
Dimethicone 5,00Dimethicone 5.00
Cetearyloctanoat 8,00Cetearyl octanoate 8.00
Makadamianussöl 5,00 Propylenglykol 5,00Macadamia nut oil 5.00 propylene glycol 5.00
Retinol 15D® 0,66Retinol 15D ® 0.66
Wasser ad 100Water ad 100
Sicovit Weiss E 171 8,00Sicovit Weiss E 171 8.00
Sicomet Braun 70 13E 3717 2,00 Ascorbinsäure 0,20Sicomet Braun 70 13E 3717 2.00 ascorbic acid 0.20
Tocopherol 0,50Tocopherol 0.50
Parfüm q.s.Perfume q.s.
Benzophenone-3 5,00Benzophenone-3 5.00
Beispiel 9Example 9
Fluid Make-up (Dekorative Kosmetik)Fluid make-up (decorative cosmetics)
% W/W Ceteareth-6 and Stearylalkohol 7,00% W / w ceteareth-6 and stearyl alcohol 7.00
Ceteareth-25 5,00Ceteareth-25 5.00
Dimethicone 5,00Dimethicone 5.00
Cetearyloctanoat 8,00Cetearyl octanoate 8.00
Makadamianussöl 5,00 Propylenglykol 5,00Macadamia nut oil 5.00 propylene glycol 5.00
Retinol 15D® 0,33Retinol 15D ® 0.33
Wasser ad 100Water ad 100
Sicovit Weiss E 171 8,00Sicovit Weiss E 171 8.00
Sicomet Braun 70 13E 3717 1,00 Ascorbinsäure 0,10Sicomet Braun 70 13E 3717 1.00 ascorbic acid 0.10
Tocopherol 0,01Tocopherol 0.01
Parfüm q.s.Perfume q.s.
Benzophenone-3 5,00 Benzophenone-3 5.00

Claims

Patentansprüche claims
1. Zubereitungen, enthaltend mindestens ein Retinoid, min- destens ein wasserlösliches Antioxidans und mindestens ein öllösliches Antioxidans, dadurch gekennzeichnet, dass in den Zubereitungen pro Gewichtsteil Retinoid mindestens 1 Gewichtsteil eines oder mehrerer wasserlöslicher Antioxidantien und 0,1 bis 100 Gewichtsteile eines oder mehrerer öllöslicher Antioxidantien vorliegen, wobei der Gehalt an einem oder mehreren wasserlöslichen Antioxidantien im Bereich von 0,05 bis 0,8 Gew.-% liegt, bezogen auf die Gesamtmenge der Zubereitungen.1. Preparations containing at least one retinoid, at least one water-soluble antioxidant and at least one oil-soluble antioxidant, characterized in that in the preparations per part by weight of retinoid at least 1 part by weight of one or more water-soluble antioxidants and 0.1 to 100 parts by weight of one or more oil-soluble Antioxidants are present, the content of one or more water-soluble antioxidants being in the range from 0.05 to 0.8% by weight, based on the total amount of the preparations.
2. Zubereitungen nach Anspruch 1, dadurch gekennzeichnet, dass es sich um kosmetische oder pharmazeutische Zubereitungen oder um Nahrungsmittelzubereitungen handelt.2. Preparations according to claim 1, characterized in that it is cosmetic or pharmaceutical preparations or food preparations.
3. Zubereitungen nach einem der Ansprüche 1 oder 2 , enthaltend pro Gewichtsteil Retinoid 1 bis 5 Gewichtsteile eines oder mehrerer wasserlöslicher Antioxidantien und 5 bis 10 Gewichtsteile eines oder mehrerer öllöslicher Antioxidantien.3. Preparations according to one of claims 1 or 2, containing 1 to 5 parts by weight of one or more water-soluble antioxidants and 5 to 10 parts by weight of one or more oil-soluble antioxidants per part by weight of retinoid.
4. Zubereitungen nach einem der Ansprüche 1 bis 3 , enthaltend pro Gewichtsteil Retinoid 2 bis 3 Gewichtsteile eines oder mehrerer wasserlöslicher Antioxidantien und 8 bis 10 Gewichtsteile eines oder mehrerer öllöslicher Antioxidantien.4. Preparations according to one of claims 1 to 3, containing 2 to 3 parts by weight of one or more water-soluble antioxidants and 8 to 10 parts by weight of one or more oil-soluble antioxidants per part by weight of retinoid.
5. Zubereitungen nach einem der Ansprüche 1 bis 4 , enthaltend als wasserlösliches Antioxidans L-Ascorbinsäure oder Salze der L-Ascorbinsäure.5. Preparations according to one of claims 1 to 4, containing as water-soluble antioxidant L-ascorbic acid or salts of L-ascorbic acid.
6. Zubereitungen nach einem der Ansprüche 1 bis 5, enthaltend als öllösliches Antioxidans α-Tocopherol.6. Preparations according to one of claims 1 to 5, containing α-tocopherol as an oil-soluble antioxidant.
7. Zubereitungen nach einem der Ansprüche 1 bis 6 , dadurch gekennzeichnet, dass es sich bei dem Retinoid um all-trans- Retinol handelt.7. Preparations according to one of claims 1 to 6, characterized in that the retinoid is all-trans retinol.
8. Zubereitungen nach Anspruch 7, enthaltend 0,005 bis 0, 5 Ge . -% all-trans-Retinol.8. Preparations according to claim 7, containing 0.005 to 0.5 Ge. -% all-trans retinol.
9. Zubereitungen nach einem der Ansprüche 1 bis 8 in Form einer O/W-, W/O- oder multiplen Emulsion. 9. Preparations according to one of claims 1 to 8 in the form of an O / W, W / O or multiple emulsion.
10. Zubereitungen nach einem der Ansprüche 1 bis 9, dadurch gekennzeichnet, dass sie in Sauerstoff-undurchlässigen Verpackungen ohne Zusatz von Schutzgas aufbewahrt werden.10. Preparations according to one of claims 1 to 9, characterized in that they are stored in oxygen-impermeable packaging without the addition of protective gas.
11. Zubereitungen nach Anspruch 10, dadurch gekennzeichnet, dass es sich bei der Verpackung um eine Aluminiumtube handelt.11. Preparations according to claim 10, characterized in that the packaging is an aluminum tube.
12. Zubereitungen nach Anspruch 11, dadurch gekennzeichnet, dass die Innenseite der Aluminiumtube mit einem Schutzlack versehen ist.12. Preparations according to claim 11, characterized in that the inside of the aluminum tube is provided with a protective lacquer.
13. Zubereitungen nach einem der Ansprüche 1 bis 12 , dadurch gekennzeichnet, dass es sich um Hautpflegezubereitungen handelt . 13. Preparations according to one of claims 1 to 12, characterized in that it is skin care preparations.
EP03766186A 2002-07-24 2003-07-16 Retinoid-containing preparations Ceased EP1526831A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10233740 2002-07-24
DE10233740A DE10233740A1 (en) 2002-07-24 2002-07-24 Preparations containing retinoids
PCT/EP2003/007700 WO2004012696A1 (en) 2002-07-24 2003-07-16 Retinoid-containing preparations

Publications (1)

Publication Number Publication Date
EP1526831A1 true EP1526831A1 (en) 2005-05-04

Family

ID=30010360

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03766186A Ceased EP1526831A1 (en) 2002-07-24 2003-07-16 Retinoid-containing preparations

Country Status (8)

Country Link
US (1) US20050202049A1 (en)
EP (1) EP1526831A1 (en)
JP (1) JP2006503000A (en)
CN (1) CN100443070C (en)
AU (1) AU2003246705A1 (en)
BR (1) BR0311563A (en)
DE (1) DE10233740A1 (en)
WO (1) WO2004012696A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005048929A2 (en) * 2003-11-13 2005-06-02 Galileo Pharmaceuticals, Inc. Plant-derived protein extract compositions and methods
DE102004003478A1 (en) * 2004-01-22 2005-08-18 Basf Ag Retinoid-containing preparations
DE102006031762A1 (en) * 2006-07-05 2008-01-10 Lancaster Group Gmbh Cosmetic preparation with a skin care complex with anti-aging effect
EP1905422A1 (en) * 2006-09-28 2008-04-02 Johnson & Johnson Consumer France SAS Stabilized compositons containing retinoids and metal oxide pigments
JPWO2008111440A1 (en) * 2007-03-09 2010-06-24 株式会社カネカ Method for stably storing reduced coenzyme Q10
HUP0700426A2 (en) * 2007-06-19 2010-03-29 Invencio 21 Gyogyhatasu Keszit Liposomal compound
JP5210699B2 (en) * 2008-04-18 2013-06-12 ピアス株式会社 Retinoid stabilizing composition, skin external preparation and cosmetic containing the composition
ES2975482T3 (en) * 2013-03-15 2024-07-08 Laboratory Skin Care Inc Compositions of fine dried particles of the retinoid active agent and topical formulations that include them
CN103417433B (en) * 2013-08-05 2015-04-22 雅露拜尔生物科技(杭州)有限公司 Whitening and freckle-removing cream with whitening and freckle-removing functions, production technology of cream, and nitrogen filling machine
MX2018001546A (en) * 2018-02-06 2019-08-07 Centro Int De Cosmiatria S A P I De C V Mx/a/2018/001546formulation and method for the treatment of androgenic alopecia.
JP7195222B2 (en) * 2019-06-24 2022-12-23 富士フイルム株式会社 oily cosmetics

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004951A (en) * 1975-07-03 1977-01-25 Kaiser Aluminum & Chemical Corporation Protective coating for aluminum products
FR2591105B1 (en) * 1985-12-11 1989-03-24 Moet Hennessy Rech PHARMACEUTICAL COMPOSITION, IN PARTICULAR DERMATOLOGICAL, OR COSMETIC, BASED ON HYDRATED LIPID LAMELLAR PHASES OR LIPOSOMES CONTAINING A RETINOIDE OR A STRUCTURAL ANALOG OF SUCH A RETINOID AS A CAROTENOID.
DE3710216A1 (en) * 1987-03-27 1988-10-06 Rentschler Arzneimittel USE OF DIHYDROERGOTAMINE AND ITS SALTS FOR LOCAL TREATMENT OF TROPHIC DISORDERS
US5583136A (en) * 1990-01-29 1996-12-10 Johnson & Johnson Consumer Products, Inc. Retinoid containing skin care compositions containing imidazoles
AU639063B2 (en) * 1990-01-29 1993-07-15 Johnson & Johnson Consumer Products, Inc. Skin care compositions
CA2090104C (en) * 1991-06-27 2002-05-28 Charles E. Clum Stabilized retinoid-containing skin care compositions
US5252604A (en) * 1992-07-10 1993-10-12 Hoffmann-La Roche Inc. Compositions of retinoic acids and tocopherol for prevention of dermatitis
EP0608433B1 (en) * 1992-07-13 2004-05-19 Shiseido Company, Ltd. Composition for dermatologic preparation
DE4420625C1 (en) * 1994-06-14 1995-11-02 Beiersdorf Ag Active substance combination with a content of glycerylalkyl ethers and cosmetic and dermatological preparations containing such active substance combinations
US6461622B2 (en) * 1994-09-07 2002-10-08 Johnson & Johnson Consumer Companies, Inc. Topical compositions
AU3633295A (en) * 1994-09-07 1996-03-27 Johnson & Johnson Consumer Products, Inc. Retinoid compositions
CN1107668A (en) * 1994-12-23 1995-09-06 广州鹰金钱企业集团公司 Nutritive liquid diet
RU2080072C1 (en) * 1994-12-28 1997-05-27 Научно-исследовательский институт детского питания Dairy product for pregnant women and nursing mothers
DE19745506A1 (en) * 1997-10-15 1999-04-22 Basf Ag Use of ascorbyl-2-phosphoric acid esters for stabilizing vitamin A and / or vitamin A derivatives in cosmetic and pharmaceutical preparations
US6790465B2 (en) * 2000-12-01 2004-09-14 Snore-Fix, Inc. Composition and method for treating snoring

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004012696A1 *

Also Published As

Publication number Publication date
BR0311563A (en) 2005-04-26
CN100443070C (en) 2008-12-17
US20050202049A1 (en) 2005-09-15
JP2006503000A (en) 2006-01-26
DE10233740A1 (en) 2004-02-05
WO2004012696A1 (en) 2004-02-12
CN1671353A (en) 2005-09-21
WO2004012696A8 (en) 2005-01-20
AU2003246705A1 (en) 2004-02-23

Similar Documents

Publication Publication Date Title
EP1305003B1 (en) Use of a combination of active substances comprising bioquinones for the manufacture of cosmetic or dermatological compositions for the treatment or the prevention of dandruff
DE69813935T2 (en) Use of retinoids to induce skin pigmentation
EP1725296A1 (en) Retinoid-containing preparations
EP1194115A1 (en) Topically applied idebenone-containing agent with protective and regenerative effect
EP1307179A2 (en) Cosmetic or dermatological preparations for avoiding skin damage caused by peroxide
WO2003059312A2 (en) Cosmetic or dermatological preparations for preventing damages to skin caused by peroxides
WO2004012696A1 (en) Retinoid-containing preparations
WO1994018942A1 (en) Synergistic combinations of sunscreening substances, cosmetic and dermatological compositions containing such combinations
EP2533752B1 (en) Preparations for stabilising/forming the texture of living tissue such as skin, and uses thereof
EP0911016B1 (en) Use of ascorbyl-2-phosphoric acid esters for stabilising vitamin a and/or vitamin a-derivatives in cosmetic and pharmaceutic compositions
EP0769291A1 (en) Active agent combination against acne and inflamed comedones
EP1214927A1 (en) Use of folic acid and/or its derivatives for the manufacture of topical compositions
WO2001062208A2 (en) Topical cosmetic agents containing 2-hydrazino-1,3-heteroazoles
DE19518845A1 (en) Cosmetic or dermatological preparations containing phytic acid
WO1994004128A2 (en) Use of radical catchers as immunomodulating agents in cosmetic and dermatological compositions
EP2356980A2 (en) Use of dihydromyricetin to combat skin ageing
RU2476225C2 (en) Use of at least one oxime 3,5-seco-4-norcholestane derivative as antioxidants
EP0706786A2 (en) Use of chlorogenic acid as antioxidant in cosmetic, especially haircosmetic compositions, and compositions containing chlorogenic acid
KR20210036166A (en) Composition for skin barrier
CN112912054B (en) Composition for reinforcing skin barrier
DE10328547A1 (en) Mixture consisting of a UV-A and a UV-B filter
DE102012214034A1 (en) Use of cosmetic or dermatological formulation in the form of oil-water emulsion having active ingredient comprising urea, carnitine and/or acyl-carnitine for tightening and strengthening of skin and for treating and/or preventing cellulite
DE10027875A1 (en) Composition useful for the treatment of skin disorders e.g. acne comprises lipoic acid, its derivative or salt having an excess of (R)-enantiomer
WO2013169008A1 (en) Antioxidant composition using xylosma congesta extracts
CN114727928A (en) Composition for inducing and promoting change of environment around aged skin cells

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050224

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ERNST, ANDREAS

Inventor name: KOEPSEL, CHRISTIAN

Inventor name: HABICH, ANDREAS

Inventor name: JENTZSCH, AXEL

17Q First examination report despatched

Effective date: 20061218

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BASF SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20091009